Page 99 - Human Use News Today

LONDON (dpa-AFX) - AstraZeneca (AZN.L, AZN) said the Committee for Medicinal Products for Human Use of the European Medicines Agency recommended authorising Imfinzi in combination with Imjudo for

(RTTNews) - Atara Biotherapeutics, Inc. (ATRA) and French healthcare company Pierre Fabre announced Monday that the European Commission (EC) has g...

Investegate announcements from AstraZeneca PLC, Enhertu approved in EU for gastric cancer

Investegate announcements from AstraZeneca PLC, Enhertu recommended for EU approval in HER2-low BC

/PRNewswire/ -- Atara Biotherapeutics, Inc. (Nasdaq: ATRA), and Pierre Fabre today announced that the European Commission (EC) has granted marketing...

MARKET WRAPS Todays Top Headlines/Must Reads: - Treasury Rally to Be Tested by Feds Next Move - U.S. Scores $4 Billion Windfall on Oil-Reserve Sales - European Energy Ministers...

A total of five drugs were recommended for approval at the CHMP’s December meeting, including a gene therapy and two cancer drugs.

Gene therapy involves adults with haemophilia B and brings renewed hope to patients across Europe - News - PharmaTimes

Investegate announcements from Sanofi - Aventis Groupe, Press Release: Dupixent® (dupilumab) recommended for EU approval by the CHMP for the treatment of eosinophilic esophagitis

Dupixent (dupilumab) recommended for EU approval by the CHMP for the treatment of eosinophilic esophagitis If approved, Dupixent would be the first and only targeted medicine specifically indicated